Altamira Therapeutics Ltd. (CYTO:NASDAQ) closed at $0.300 on March 9, 2026, unchanged on the day. It is trading at its 52-week high of $0.300. Altamira Therapeutics Ltd. is part of the Health Care sector.
In 252 trading sessions since October 22, 2025, CYTO closed higher on 0 days (0%). Its best day was October 22, 2025 (0.00%) and its worst was October 22, 2025 (0.00%). It never moved 10% or more in a single session. It opened at least 5% above the previous day's high 252 times.
Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens.
Find more stocks like CYTO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.